H1B Report
Side-by-side comparison

Mylan Pharmaceuticals, Inc. vs WIPRO LIMITED

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Mylan Pharmaceuticals, Inc.
PARank #FEIN 55-0455423
Entity B
WIPRO LIMITED
NJRank #5FEIN 98-0154401

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricMylan Pharmaceuticals, Inc.WIPRO LIMITED
Total filings13271,022▲
Certified %79.55%91.54%▲
Denied %1.52%0.38%▲
Withdrawn %2.27%1.34%
Cert-withdrawn %16.67%6.74%
Rank—#5
Active yearsFY2010–FY2025FY2010–FY2026
Worksite statePANJ

Outcomes — Mylan Pharmaceuticals, Inc.

DOL case-status mix.

Outcome breakdown: Certified 79.5%, Cert-withdrawn 16.7%, Withdrawn 2.3%, Denied 1.5%
Outcome breakdown
OutcomeShare
Certified79.5%
Cert-withdrawn16.7%
Withdrawn2.3%
Denied1.5%
Certified79.5%
Cert-withdrawn16.7%
Withdrawn2.3%
Denied1.5%

Outcomes — WIPRO LIMITED

DOL case-status mix.

Outcome breakdown: Certified 91.5%, Cert-withdrawn 6.7%, Withdrawn 1.3%, Denied 0.4%
Outcome breakdown
OutcomeShare
Certified91.5%
Cert-withdrawn6.7%
Withdrawn1.3%
Denied0.4%
Certified91.5%
Cert-withdrawn6.7%
Withdrawn1.3%
Denied0.4%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Mylan Pharmaceuticals, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20104
FY201111
FY20126
FY201314
FY201417
FY201514
FY201620
FY201712
FY201815
FY201913
FY20200
FY20211
FY20220
FY20231
FY20241
FY20253
FY20260
WIPRO LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20103,018
FY20113,025
FY20126,933
FY20136,525
FY20148,008
FY201511,733
FY201610,233
FY20174,938
FY20186,036
FY20194,053
FY202094
FY2021128
FY202297
FY2023554
FY20242,296
FY20252,289
FY20261,062

Top 5 occupations — Mylan Pharmaceuticals, Inc.

Top 5 occupations — WIPRO LIMITED

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.
Swap A: Mylan Pharmaceuticals, Inc.
INFOSYS LIMITEDTATA CONSULTANCY SERVICES LIMITEDCOGNIZANT TECHNOLOGY SOLUTIONS US CORPDeloitte Consulting LLP
Swap B: WIPRO LIMITED
INFOSYS LIMITEDTATA CONSULTANCY SERVICES LIMITEDCOGNIZANT TECHNOLOGY SOLUTIONS US CORPDeloitte Consulting LLP
Or browse the full sponsor index.
Mylan Pharmaceuticals, Inc.WIPRO LIMITEDBrowse all